| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Urological Research Laboratory, USC/Norris Comprehensive Cancer Center [M. G-Z., C. M. B., A. S. Y., T. N., J. M. V., P. A. J.], and Department of Colorectal Surgery [R. W. B.], University of Southern California, School of Medicine, Los Angeles, California 90033
Loss of heterozygosity on 9p21, where the p16/CDKN2 tumor suppressor and the p15INK4B cell cycle regulator genes are located, is a common genetic alteration in bladder cancer. However, it has been difficult to demonstrate homozygous deletions and intragenic mutations in either of these two genes in primary transitional cell carcinomas (TCC) of the bladder. Similarly, colon cancer-derived cell lines have shown no homozygous deletions of the p16/CDKN2 locus in contrast to a wide variety of tumor-derived cell lines. We have investigated abnormal methylation of the 5' CpG islands of the p16/CDKN2 and p15INK4B genes as an alternative mechanism of inactivation of these genes in bladder and colon cancers. De novo methylation of the 5' CpG island of p16/CDKN2 was observed in 12 of 18 (67%) uncultured bladder TCCs and in 2 of 3 (67%) bladder cell lines. In contrast, only 1 of 10 (10%) colon carcinomas showed methylation of the 5' CpG island of p16/CDKN2. It was striking to find that this region was extensively methylated and the gene not expressed in the normal colonic mucosa of 6 of 10 (60%) patients with colon cancer, whereas 5 of the corresponding colon tumors showed no methylation and high levels of p16/CDKN2 expression. Our data show a significant correlation (P = 0.00001, two-sided) between the absence of p16/CDKN2 expression and methylation of its 5' CpG island in bladder tumors, cell lines, and normal colon mucosa. In contrast, no association was observed between expression and methylation status of the 5' CpG island of p15INK4B. Our results suggest that the p16/CDKN2 tumor suppressor gene may be inactivated by methylation of its 5' CpG island in TCCs of the bladder. We also present evidence of methylation of the 5' CpG island in this autosomal gene in normal colonic tissue.
1 Supported by USPHS Grant R35CA49758 from the National Cancer Institute.
2 To whom requests requests for reprints should be addressed, at USC/Norris Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA 90033. Phone: (213) 764-0816; Fax: (213) 764-0102.
Received 6/20/95. Accepted 8/30/95.
This article has been cited by other articles:
|
|
 |
|
  C. B. Yoo, J. C. Chuang, H.-M. Byun, G. Egger, A. S. Yang, L. Dubeau, T. Long, P. W. Laird, V. E. Marquez, and P. A. Jones Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice Cancer Prevention Research, September 1, 2008; 1(4): 233 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Esteller Epigenetics in Cancer N. Engl. J. Med., March 13, 2008; 358(11): 1148 - 1159. [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Rauch, X. Zhong, X. Wu, M. Wang, K. H. Kernstine, Z. Wang, A. D. Riggs, and G. P. Pfeifer High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer PNAS, January 8, 2008; 105(1): 252 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Yoo, S. Jeong, G. Egger, G. Liang, P. Phiasivongsa, C. Tang, S. Redkar, and P. A. Jones Delivery of 5-Aza-2'-Deoxycytidine to Cells Using Oligodeoxynucleotides Cancer Res., July 1, 2007; 67(13): 6400 - 6408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Esteller Epigenetic gene silencing in cancer: the DNA hypermethylome Hum. Mol. Genet., April 15, 2007; 16(R1): R50 - R59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Egger, A. M. Aparicio, S. G. Escobar, and P. A. Jones Inhibition of Histone Deacetylation Does Not Block Resilencing of p16 after 5-Aza-2'-Deoxycytidine Treatment Cancer Res., January 1, 2007; 67(1): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jang, J. B. Mason, and S.-W. Choi Genetic and Epigenetic Interactions between Folate and Aging in Carcinogenesis J. Nutr., December 1, 2005; 135(12): 2967S - 2971S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tian, V. Jurukovski, L. Yuan, J. Shan, and H. Xu WTH3, which Encodes a Small G Protein, Is Differentially Regulated in Multidrug-Resistant and Sensitive MCF7 Cells Cancer Res., August 15, 2005; 65(16): 7421 - 7428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, L.-E Wang, L. Wang, K. H. Lu, G. B. Mills, M. L. Bondy, and Q. Wei Methylation and Messenger RNA Expression of p15INK4b but Not p16INK4a Are Independent Risk Factors for Ovarian Cancer Clin. Cancer Res., July 1, 2005; 11(13): 4968 - 4976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Cote, P. W. Laird, and R. H. Datar Promoter Hypermethylation: A New Therapeutic Target Emerges in Urothelial Cancer J. Clin. Oncol., May 1, 2005; 23(13): 2879 - 2881. [Full Text] [PDF]
|
|
|
|
|
|
T. Ogishima, H. Shiina, J. E. Breault, L. Tabatabai, W. W. Bassett, H. Enokida, L.-C. Li, T. Kawakami, S. Urakami, L. A. Ribeiro-Filho, et al. Increased Heparanase Expression Is Caused by Promoter Hypomethylation and Up-Regulation of Transcriptional Factor Early Growth Response-1 in Human Prostate Cancer Clin. Cancer Res., February 1, 2005; 11(3): 1028 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sun, D. Deng, W.-C. You, H. Bai, L. Zhang, J. Zhou, L. Shen, J.-L. Ma, Y.-Q. Xie, and J.-Y. Li Methylation of p16 CpG Islands Associated with Malignant Transformation of Gastric Dysplasia in a Population-Based Study Clin. Cancer Res., August 1, 2004; 10(15): 5087 - 5093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Strathdee, B.R. Davies, J.K. Vass, N. Siddiqui, and R. Brown Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene Carcinogenesis, May 1, 2004; 25(5): 693 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ueki, A. W. Hsing, Y.-T. Gao, B.-S. Wang, M.-C. Shen, J. Cheng, J. Deng, J. F. Fraumeni Jr., and A. Rashid Alterations of p16 and Prognosis in Biliary Tract Cancers from a Population-Based Study in China Clin. Cancer Res., March 1, 2004; 10(5): 1717 - 1725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Cheng, D. J. Weisenberger, F. A. Gonzales, G. Liang, G.-L. Xu, Y.-G. Hu, V. E. Marquez, and P. A. Jones Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells Mol. Cell. Biol., February 1, 2004; 24(3): 1270 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Weisenberger, M. Velicescu, J. C. Cheng, F. A. Gonzales, G. Liang, and P. A. Jones Role of the DNA Methyltransferase Variant DNMT3b3 in DNA Methylation Mol. Cancer Res., January 1, 2004; 2(1): 62 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. De Larco, B. R. K. Wuertz, D. Yee, B. L. Rickert, and L. T. Furcht Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells PNAS, November 25, 2003; 100(24): 13988 - 13993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Holst, G. J. Nuovo, M. Esteller, K. Chew, S. B. Baylin, J. G. Herman, and T. D. Tlsty Methylation of p16INK4a Promoters Occurs in Vivo in Histologically Normal Human Mammary Epithelia Cancer Res., April 1, 2003; 63(7): 1596 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Roca, R. M. Kypta, and M. d. M. Vivanco Loss of p16INK4a results in increased glucocorticoid receptor activity during fibrosarcoma development PNAS, March 18, 2003; 100(6): 3113 - 3118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Cheng, C. B. Matsen, F. A. Gonzales, W. Ye, S. Greer, V. E. Marquez, P. A. Jones, and E. U. Selker Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine J Natl Cancer Inst, March 5, 2003; 95(5): 399 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Abdollahi, D. Pisarcik, D. Roberts, J. Weinstein, P. Cairns, and T. C. Hamilton LOT1 (PLAGL1/ZAC1), the Candidate Tumor Suppressor Gene at Chromosome 6q24-25, Is Epigenetically Regulated in Cancer J. Biol. Chem., February 14, 2003; 278(8): 6041 - 6049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Tam, T. R. Devereux, A. C. Patel, J. F. Foley, R. R. Maronpot, and T. E. Massey Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors Carcinogenesis, January 1, 2003; 24(1): 121 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Jeronimo, R Henrique, P F Campos, J Oliveira, O L Caballero, C Lopes, and D Sidransky Endothelin B receptor gene hypermethylation in prostate adenocarcinoma J. Clin. Pathol., January 1, 2003; 56(1): 52 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Berggren, R. Kumar, S. Sakano, L. Hemminki, T. Wada, G. Steineck, J. Adolfsson, P. Larsson, U. Norming, H. Wijkstrom, et al. Detecting Homozygous Deletions in the CDKN2A(p16INK4a)/ARF(p14ARF) Gene in Urinary Bladder Cancer Using Real-Time Quantitative PCR Clin. Cancer Res., January 1, 2003; 9(1): 235 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M van Rijnsoever, F Grieu, H Elsaleh, D Joseph, and B Iacopetta Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands Gut, December 1, 2002; 51(6): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Johanning, D. C. Heimburger, and C. J. Piyathilake DNA Methylation and Diet in Cancer , J. Nutr., December 1, 2002; 132(12): 3814S - 3818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Nguyen, D. J. Weisenberger, M. Velicescu, F. A. Gonzales, J. C. Y. Lin, G. Liang, and P. A. Jones Histone H3-Lysine 9 Methylation Is Associated with Aberrant Gene Silencing in Cancer Cells and Is Rapidly Reversed by 5-Aza-2'-deoxycytidine Cancer Res., November 15, 2002; 62(22): 6456 - 6461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tokugawa, H. Sugihara, T. Tani, and T. Hattori Modes of Silencing of p16 in Development of Esophageal Squamous Cell Carcinoma Cancer Res., September 1, 2002; 62(17): 4938 - 4944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Chapman, S. M. Knoepp, M. K. Byeon, K. W. Henderson, and C. W. Schweinfest The Colon Anion Transporter, Down-Regulated in Adenoma, Induces Growth Suppression That Is Abrogated by E1A Cancer Res., September 1, 2002; 62(17): 5083 - 5088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsuda, T. Takarabe, Y. Kanai, T. Fukutomi, and S. Hirohashi Correlation of DNA Hypomethylation at Pericentromeric Heterochromatin Regions of Chromosomes 16 and 1 with Histological Features and Chromosomal Abnormalities of Human Breast Carcinomas Am. J. Pathol., September 1, 2002; 161(3): 859 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Birkenkamp-Demtroder, L. L. Christensen, S. H. Olesen, C. M. Frederiksen, P. Laiho, L. A. Aaltonen, S. Laurberg, F. B. Sorensen, R. Hagemann, and T. F. Orntoft Gene Expression in Colorectal Cancer Cancer Res., August 1, 2002; 62(15): 4352 - 4363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ballestar and M. Esteller The impact of chromatin in human cancer: linking DNA methylation to gene silencing Carcinogenesis, July 1, 2002; 23(7): 1103 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Straume, J. Smeds, R. Kumar, K. Hemminki, and L. A. Akslen Significant Impact of Promoter Hypermethylation and the 540 C>T Polymorphism of CDKN2A in Cutaneous Melanoma of the Vertical Growth Phase Am. J. Pathol., July 1, 2002; 161(1): 229 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hewitt, C. Lee Wu, G. Evans, A. Howell, R. G. Elles, R. Jordan, P. Sloan, A. P. Read, and N. Thakker Germline mutation of ARF in a melanoma kindred Hum. Mol. Genet., May 16, 2002; 11(11): 1273 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gasco, A. K. Bell, V. Heath, A. Sullivan, P. Smith, L. Hiller, I. Yulug, G. Numico, M. Merlano, P. J. Farrell, et al. Epigenetic Inactivation of 14-3-3 {sigma} in Oral Carcinoma: Association with p16INK4a Silencing and Human Papillomavirus Negativity Cancer Res., April 1, 2002; 62(7): 2072 - 2076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Velicescu, D. J. Weisenberger, F. A. Gonzales, Y. C. Tsai, C. T. Nguyen, and P. A. Jones Cell Division Is Required for de Novo Methylation of CpG Islands in Bladder Cancer Cells Cancer Res., April 1, 2002; 62(8): 2378 - 2384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Dominguez, J. Carballido, J. Silva, J. M. Silva, J. M. Garcia, J. Menendez, M. Provencio, P. Espana, and F. Bonilla p14ARF Promoter Hypermethylation in Plasma DNA as an Indicator of Disease Recurrence in Bladder Cancer Patients Clin. Cancer Res., April 1, 2002; 8(4): 980 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Liang, M. F. Chan, Y. Tomigahara, Y. C. Tsai, F. A. Gonzales, E. Li, P. W. Laird, and P. A. Jones Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements Mol. Cell. Biol., January 15, 2002; 22(2): 480 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matsukura, K. Miyazaki, H. Yakushiji, A. Ogawa, K. Harimaya, Y. Nakabeppu, and M. Sekiguchi Expression and Prognostic Significance ofO6-Methylguanine-DNA Methyltransferase in Hepatocellular, Gastric, and Breast Cancers Ann. Surg. Oncol., December 1, 2001; 8(10): 807 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Chan, R. van Amerongen, T. Nijjar, E. Cuppen, P. A. Jones, and P. W. Laird Reduced Rates of Gene Loss, Gene Silencing, and Gene Mutation in Dnmt1-Deficient Embryonic Stem Cells Mol. Cell. Biol., November 15, 2001; 21(22): 7587 - 7600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nguyen, G. Liang, T. T. Nguyen, D. Tsao-Wei, S. Groshen, M. Lubbert, J.-H. Zhou, W. F. Benedict, and P. A. Jones Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic Cells J Natl Cancer Inst, October 3, 2001; 93(19): 1465 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R S Houlston What we could do now: molecular pathology of colorectal cancer Mol. Pathol., August 1, 2001; 54(4): 206 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D.C. Markl, J. Cheng, G. Liang, D. Shibata, P. W. Laird, and P. A. Jones Global and Gene-specific Epigenetic Patterns in Human Bladder Cancer Genomes Are Relatively Stable in Vivo and in Vitro over Time Cancer Res., August 1, 2001; 61(15): 5875 - 5884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yuan, R. Mendez, A. Sahin, and J. L. Dai Hypermethylation Leads to Silencing of the SYK Gene in Human Breast Cancer Cancer Res., July 1, 2001; 61(14): 5558 - 5561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Stadler, G. Steinberg, X. Yang, F. Hagos, C. Turner, and O. I. Olopade Alterations of the 9p21 and 9q33 Chromosomal Bands in Clinical Bladder Cancer Specimens by Fluorescence in Situ Hybridization Clin. Cancer Res., June 1, 2001; 7(6): 1676 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F Costello and C. Plass Methylation matters J. Med. Genet., May 1, 2001; 38(5): 285 - 303. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Pao, M. Tsutsumi, G. Liang, E. Uzvolgyi, F. A. Gonzales, and P. A. Jones The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells Hum. Mol. Genet., April 1, 2001; 10(9): 903 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esteller, P. G. Corn, S. B. Baylin, and J. G. Herman A Gene Hypermethylation Profile of Human Cancer Cancer Res., April 1, 2001; 61(8): 3225 - 3229. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. R. Karpf, B. C. Moore, T. O. Ririe, and D. A. Jones Activation of the p53 DNA Damage Response Pathway after Inhibition of DNA Methyltransferase by 5-Aza-2'-deoxycytidine Mol. Pharmacol., April 1, 2001; 59(4): 751 - 757. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. B. Rosas, W. Koch, M. d. G. d. C. Carvalho, L. Wu, J. Califano, W. Westra, J. Jen, and D. Sidransky Promoter Hypermethylation Patterns of p16, O6-Methylguanine-DNA-methyltransferase, and Death-associated Protein Kinase in Tumors and Saliva of Head and Neck Cancer Patients Cancer Res., February 1, 2001; 61(3): 939 - 942. [Abstract] [Full Text]
|
|
|
|
|
|
P. Schraml, K. Struckmann, R. Bednar, W. Fu, T. Gasser, K. Wilber, J. Kononen, G. Sauter, M. J. Mihatsch, and H. Moch CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas : Evidence for a Second Tumor Suppressor Gene Proximal to CDKN2A Am. J. Pathol., February 1, 2001; 158(2): 593 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esteller, S. Gonzalez, R. A. Risques, E. Marcuello, R. Mangues, J. R. Germa, J. G. Herman, G. Capella, and M. A. Peinado K-ras and p16 Aberrations Confer Poor Prognosis in Human Colorectal Cancer J. Clin. Oncol., January 15, 2001; 19(2): 299 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Thompson, J. M. Maris, M. D. Hogarty, R. C. Seeger, C. P. Reynolds, G. M. Brodeur, and P. S. White Homozygous Deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at Other Tumor Suppressor Loci in Neuroblastoma Cancer Res., January 1, 2001; 61(2): 679 - 686. [Abstract] [Full Text]
|
|
|
|
|
|
F J Hernandez-Blazquez, M Habib, J-M Dumollard, C Barthelemy, M Benchaib, A de Capoa, and A Niveleau Evaluation of global DNA hypomethylation in human colon cancer tissues by immunohistochemistry and image analysis Gut, November 1, 2000; 47(5): 689 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Patel, C. H. Anna, J. F. Foley, P. S. Stockton, F. L. Tyson, J.C. Barrett, and T. R. Devereux Hypermethylation of the p16 Ink4a promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines Carcinogenesis, September 1, 2000; 21(9): 1691 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Liang, K. D. Robertson, C. Talmadge, J. Sumegi, and P. A. Jones The Gene for a Novel Transmembrane Protein Containing Epidermal Growth Factor and Follistatin Domains Is Frequently Hypermethylated in Human Tumor Cells Cancer Res., September 1, 2000; 60(17): 4907 - 4912. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Fuxe, G. Akusjärvi, H. M. Goike, G. Roos, V. P. Collins, and R. F. Pettersson Adenovirus-mediated Overexpression of p15INK4B Inhibits Human Glioma Cell Growth, Induces Replicative Senescence, and Inhibits Telomerase Activity Similarly to p16INK4A Cell Growth Differ., July 1, 2000; 11(7): 373 - 384. [Abstract] [Full Text]
|
|
|
|
|
|
S. Sarkar, K. P. Jülicher, M. S. Burger, V. Della Valle, C.-J. Larsen, T. R. Yeager, T. B. Grossman, R. W. Nickells, C. Protzel, D. F. Jarrard, et al. Different Combinations of Genetic/Epigenetic Alterations Inactivate the p53 and pRb Pathways in Invasive Human Bladder Cancers Cancer Res., July 1, 2000; 60(14): 3862 - 3871. [Abstract] [Full Text]
|
|
|
|
|
|
M. Widschwendter, J. Berger, M. Hermann, H. M. Muller, A. Amberger, M. Zeschnigk, A. Widschwendter, B. Abendstein, A. G. Zeimet, G. Daxenbichler, et al. Methylation and Silencing of the Retinoic Acid Receptor-{beta}2 Gene in Breast Cancer J Natl Cancer Inst, May 17, 2000; 92(10): 826 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Salem, G. Liang, Y. C. Tsai, J. Coulter, M. A. Knowles, A.-C. Feng, S. Groshen, P. W. Nichols, and P. A. Jones Progressive Increases in de Novo Methylation of CpG Islands in Bladder Cancer Cancer Res., May 1, 2000; 60(9): 2473 - 2476. [Abstract] [Full Text] |
